Loading
Latest filing published 01 Jun 2023 for iSpecimen Inc., €5,143.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Tracy Curley in iSpecimen Inc. Between 16 November 2021 and 31 May 2023, the trades on record add up to 4 filings.
No open-market sale appears; the market trades are 3 purchases worth €51k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 1 share grant. Since January 2023: 1 purchase and no sales on the market.
The median purchase comes to €9,045. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The newest entry dates from 1 June 2023: an open-market purchase of €5,143, in iSpecimen Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations